While Johnson & Johnson’s Cordis withdrew from India, companies such as Abbott Laboratories - Vascular, Boston Scientific Corporation, Medtronic Inc. and other players like Biotronik, Sahajanand Medical Technologies, Meril Life Sciences and Translumina Therapeutics are vying to expand their presence in India through investments in the coronary stent market, according...